Hermann Luebbert - 04 Mar 2026 Form 4 Insider Report for Biofrontera Inc. (BFRI)

Reporting relationship: CEO & Chairman, Director
Issuer ticker: BFRI
Reported as of: 04 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Mar 2026, 21:31:43 UTC
Prior SEC filing: 16 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Daniel Hakansson, Attorney-in-fact for Hermann Luebbert

Key filing fact

Hermann Luebbert filed Form 4 for Biofrontera Inc. (BFRI) on 06 Mar 2026.

Key facts

This page summarizes Hermann Luebbert's Form 4 filing for Biofrontera Inc. (BFRI).
4 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 06 Mar 2026, 21:31.

Change

Previous filing in this sequence was filed on 16 Sep 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001886492 Primary reporting owner

Luebbert Hermann

Relationship: CEO & Chairman, Director
Address: 660 MAIN STREET, FIRST FLOOR, WOBURN
Signature: /s/ Daniel Hakansson, Attorney-in-fact for Hermann Luebbert
Signature date: 06 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BFRI transaction

Common Stock

Options Exercise

Transaction value
Shares: +137,500
Change %: +90%
Price
Shares after: 290,211
Date: 05 Mar 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BFRI transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares: +125,000
Change %
Price: $0.000000^*
Shares after: 125,000
Date: 04 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 125,000
Exercise price
Footnotes: F2, F3, F6

BFRI transaction Derivative

Employee stock option (right to buy)

Award

Transaction value
Shares: +125,000
Change %
Price: $0.000000^*
Shares after: 125,000
Date: 04 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 125,000
Exercise price: $0.9000
Footnotes: F4, F7

BFRI transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -137,500
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 05 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 137,500
Exercise price
Footnotes: F1, F5, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Restricted stock units convert into common stock on a one-for-one basis.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of BFRI common stock, subject to the company's discretion to settle the restricted stock units, in whole or in part, in cash, as discussed below in footnote 3. The reporting person received the restricted stock units as an award for no consideration.

Footnote F3

The restricted stock units vest in two equal yearly installments for the first two years following the grant date, beginning on March 4, 2027. Each vested restricted stock unit will be settled, at the Company's discretion, in shares, cash or a combination of shares and cash within 60 days of the vesting date.

Footnote F4

The option vests in two equal installments, the first of which will take place on September 4, 2026 and the second of which will take place on March 4, 2027.

Footnote F5

On July 12, 2024 the reporting person was granted 275,000 restricted stock units, vesting in two equal semi-annual installments with the first tranche vesting on January 12, 2025 and the second tranche on July 12, 2025, with each to be settled, at the Company's discretion, in shares, cash or a combination of shares and cash within 60 days of the vesting date. A Form 4 filed by the reporting person on September 16, 2025 incorrectly identified the vesting schedule for these restricted stock units as being "two equal annual installments beginning on July 12, 2025." Relatedly, due to an administrative error, the first tranche was settled on September 10, 2025 and the second tranche was settled on March 5, 2026.

Footnote F6

Restricted stock units with different terms are not included.

Footnote F7

Options with different terms are not included.